2. Induced Disease Models Products
  3. Cancer Models
  4. Bladder Cancer Models

Bladder Cancer Models

Bladder Cancer Models (3):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-34758
    N-Nitroso-N-methylurea 684-93-5 ≥98.0%
    N-Nitroso-N-methylurea (NMU;MNU;NMH) is a potent carcinogen, mutagen and teratogenand. N-Nitroso-N-methylurea is a direct-acting alkylating agent that interacts with DNA. N-Nitroso-N-methylurea targets multiple animal organs to cause various cancer and/or degenerative disease. N-Nitroso-N-methylurea is also a precursor in the synthesis of diazomethane.
    N-Nitroso-N-methylurea
  • HY-W755252
    N-Butyl-N-(4-hydroxybutyl)nitrosamine 3817-11-6 99.68%
    N-Butyl-N-(4-hydroxybutyl)nitrosamine is a potent mutagen that can cause high-level of mutagenesis specifically in the epithelial cells (urothelial) of the urinary bladder. N-Butyl-N-(4-hydroxybutyl)nitrosamine is used to induce bladder cancer in rodents.
    N-Butyl-N-(4-hydroxybutyl)nitrosamine
  • HY-171732
    FANFT 24554-26-5
    FANFT is an orally active and potent uroepithelial carcinogen. FANFT is metabolized to ANFT in vivo, which induces gene mutations and malignant cell transformation. FANFT efficiently induces bladder tumors in mice.
    FANFT